SBIR/STTR Research Award

Blue-Green Fiber Laser for Biomedical Applications

Award identifier 498eda978cd1355d3a4f64070ed6a33971f2726963c6abb9d2d63151110a7c75Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$901,196

Program and phase

SBIR · Phase II

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INTELLIGENT OPTICAL SYSTEMS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
NLDHG92SMX37
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The simultaneous detection of the fluorescence of marker dyes in a reference and in the sample using an excitation source with 2 distinct illumination wavelengths in the blue-green portion of the visible spectrum is a widely practiced analytical tool. This approach has been used in the most capable automated DNA sequencers, and a number of other biomedical instruments. To achieve this, current machines use either 2 gas lasers with blue and green lines, or 2 lines from an argon ion laser. These laser light sources are bulky, power inefficient, and expensive. A low cost blue-green laser that is compact and provides high output power is highly desirable. Such a device will have a tremendous positive impact on health science related instrument designs. One (1) solution to achieve this aim is the development of a dual wavelength (blue-green) optical fiber lasing cavity based laser source. Such a source has a number of advantages over solid crystal and gas based devices and is considered ideal for developing miniature inexpensive lasers for biomedical applications. Yb-doped optical fiber stands out, in particular, because of its 2 absorption bands. This characteristic shows promise for the development of a dual-line laser. In this project, our overall aim is to develop a double clad single mode Yb-doped fiber based laser emitting at 2 visible lines: blue (489 nm), and green (519 nm). This will be achieved by frequency doubling the primary emission lines of Ytterbium (Yb) at ?=978 nm and ?=1038 nm. In Phase I, we demonstrated the feasibility of generating blue and green lines from Ytterbium-doped fiber. In Phase II, we will fabricate and test a working prototype of the blue-green laser for biomedical applications. In the long term, the commercial availability of this dual wavelength laser light source will enable the creation of automatic DNA sequencers that are much smaller and less expensive than present models, are less costly to operate, and will provide higher sequencing speed and accuracy.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

264 SBIR/STTR records share this UEI (1998–2025). Reported award amounts total $77,140,779. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, Environmental Protection Agency, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.